{
  "paper_metadata": {
    "pmid": "38532802",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant p.Val50Met, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "36-year-old female",
        "phenotype": "symptomatic hereditary transthyretin-related amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 3,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 36,
          "age_at_onset": 30,
          "age_at_diagnosis": 36,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "symptomatic hereditary transthyretin-related amyloidosis with progressive lower limb small fiber neuropathy and mild autonomic symptoms.",
          "evidence_sentence": "This 36-year-old woman was diagnosed with symptomatic hereditary transthyretin-related (hATTR) amyloidosis due to a p.Val50Met TTR mutation in 2017."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "developed hATTR amyloidosis.",
          "evidence_sentence": "Her father died of hATTR amyloidosis at the age of 38 years old."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "developed hATTR amyloidosis.",
          "evidence_sentence": "Two siblings also developed the disease."
        }
      ],
      "functional_data": {
        "summary": "The p.Val50Met variant is associated with hereditary transthyretin-related amyloidosis, leading to neuropathy.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in the family.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The penetrance data indicates that all known carriers in the family are affected.",
      "key_quotes": [
        "Her father died of hATTR amyloidosis at the age of 38 years old and two siblings also developed the disease.",
        "Her first symptoms started in 2017, at the age of 30, with a progressive lower limb small fiber neuropathy and mild autonomic symptoms."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR variant was extracted successfully."
  }
}